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and morbidity after coronary artery bypass grafting?
Niv Ad, MD,a Scott D. Barnett, PhD,a Constance K. Haan, MD, MS,b Sean M. O’Brien, PhD,c Sarah Milford–Beland, MS,c and
Alan M. Speir, MDa
Objectives: Preoperative atrial fibrillation has been associated with less favorable outcomes in patients undergo-
ing coronary artery bypass grafting. However, it was never investigated in a large cohort of patients using a na-
tional database. This study aims to (1) identify the effect of atrial fibrillation on operative mortality and morbidity
in patients undergoing isolated coronary artery bypass grafting and (2) identify the potential effect of atrial fibril-
lation on patients with decreased left ventricular ejection fraction (40%).
Methods: The Society of Thoracic Surgeons National Adult Cardiac Surgery Database was used for patients with
coronary artery disease undergoing isolated coronary artery bypass grafting (n ¼ 281,567). The association be-
tween atrial fibrillation and outcomes was estimated within 3 categories of low (ejection fraction,<40%), mod-
erate (ejection fraction, 40%–55%), or normal (ejection fraction,>55%) systolic function.
Results: Patients with atrial fibrillation were found to be older and have a higher incidence of comorbidities. A
higher incidence of all major complications and mortality after surgical intervention was documented. An inter-
action between atrial fibrillation and an ejection fraction of greater than 40% for mortality, stroke, prolonged ven-
tilation, and prolonged length of stay was identified.
Conclusions: Our findings suggest that preoperative atrial fibrillation is associated with an increased risk for
perioperative mortality and morbidity in patients undergoing coronary artery bypass grafting. The negative
effect of atrial fibrillation might be more significant in patients undergoing coronary artery bypass grafting
with an ejection fraction of greater than 40%. Both the EuroSCORE and, until recently, the Society of
Thoracic Surgeons risk calculator do not include atrial fibrillation as a potential risk modifier; however, based
on this study, it should be identified as a variable to be investigated and incorporated into future risk
calculators.Atrial fibrillation is a very common arrhythmia affecting
several million patients with a median age of 70 years in
the United States.1 The average age for patients treated sur-
gically for ischemic heart disease is increasing, and as a re-
sult, it is not uncommon to have candidates for cardiac
surgery presenting with concomitant atrial fibrillation. A
few large cohort studies have recently recognized atrial fi-
brillation as a marker for increased cardiovascular morbidity
and mortality.2 This, together with the increased prevalence
of atrial fibrillation in patients undergoing cardiac surgery,
makes it important to assess the potential effect of the ar-
rhythmia on outcome after surgical intervention using a large
surgical database. Preoperative atrial fibrillation among pa-
tients undergoing coronary artery bypass grafting (CABG)
has been shown to be associated with higher mortality and
morbidity.3,4 Nevertheless, atrial fibrillation was never intro-
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doi:10.1016/j.jtcvs.2008.09.050The Journal of Thoracic andduced as a variable in the most commonly used risk calcula-
tors for cardiac surgery, such as the EuroSCORE and the
Society of Thoracic Surgeons (STS) risk score (as recently
incorporated by STS version 2.61), and subsequently has
rarely been considered to be a variable of significance
when discussing the risk and benefits of the surgical proce-
dure with the referring physicians, payers, and patients.
Theoretically, preoperative atrial fibrillation might pose
a higher clinical relevance in patients who present for surgi-
cal intervention with a low ejection fraction (EF) and con-
gestive heart failure. In addition, patients with pre-existing
atrial fibrillation are at a higher risk for time-related mortal-
ity after CABG.2,4 However, one of the challenges is to de-
termine whether atrial fibrillation is a marker or causally
related factor in less favorable outcomes, and this might re-
quire a prospective clinical trial to compare matched groups
of candidates for surgical intervention with and without
atrial fibrillation. The current literature dealing with this
question is based on retrospective reports, most of them
based on a single institution’s experience. Therefore by us-
ing data from the STS Adult Cardiac Surgery Database,
the present study was designed to identify the potential effect
of preoperative atrial fibrillation on the operative mortality
and morbidity in a large cohort of patients with coronary ar-
tery disease undergoing isolated CABG to identify the po-
tential association with reduced left ventricular function.Cardiovascular Surgery c Volume 137, Number 4 901
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CABG ¼ coronary artery bypass grafting
EF ¼ ejection fraction
OR ¼ odds ratio
STS ¼ Society of Thoracic Surgeons
MATERIALS AND METHODS
This is a prospective cohort observational study using data from the STS
National Adult Cardiac Surgery Database data collection platform for sur-
gical data collected during the years 2002 and 2003. This platform allows
prospective data collection from multiple institutions with agreed defini-
tions.
Subjects were patients undergoing isolated CABG. The STS data collec-
tion versions used were 2.35 and 2.41. EF was classified as low (<40%),
moderate (40%–55%), or normal (>55%). Outcomes of interest were op-
erative mortality, reoperation, permanent stroke, prolonged ventilation (>24
hours), renal failure, and prolonged postoperative length of stay (>14 days).
Baseline demographic characteristics, preoperative risk factors, and out-
comes of interest were compared between patients with and without preop-
erative atrial fibrillation. Continuous variables were categorized, and all
variables were described as frequencies, with c2 tests for comparisons be-
tween groups. We used regression splines to model the association between
EF and the outcome without assuming strict linearity. We first performed
unadjusted comparisons and then adjusted for a broad range of patient pre-
operative characteristics, which included age, body mass index, EF, glomer-
ular filtration rate/dialysis, male sex, white race, smoking status, family
history of coronary artery disease, diabetes, hypercholesterolemia, hyper-
tension, cerebrovascular accident, infectious endocarditis, chronic lung
disease, immunosuppressive treatment, peripheral vascular disease/
cerebrovascular disease, any previous cardiovascular interventions, triple-
vessel disease, congestive heart failure, myocardial infarction/timing of
myocardial infarction, angina/angina type, resuscitation, New York Heart
Association class IV, left main disease, and status/cardiogenic shock. In
the CABG combined with mitral valve surgery group, we also adjusted
for whether patients had mitral stenosis, moderate-to-severe mitral insuffi-
ciency, or both. All adjusted analyses were performed with generalized es-
timating equation models to account for correlations among clustered
responses (eg, within-hospital correlations). Patients without preoperative
atrial fibrillation serve as the reference group for all odds ratio (OR) compar-
isons.
We further investigated whether significant interactions exist between
atrial fibrillation and the following continuous variables: EF, age, and
body mass index. On finding evidence of a significant interaction effect be-
tween atrial fibrillation and EF with respect to several outcomes in the iso-
lated CABG group, we estimated unadjusted and adjusted ORs for the effect
of atrial fibrillation (vs no atrial fibrillation) on complications and mortality
within each EF group to serve as comparisons that demonstrate the change
in effect caused by adjustment. A P value of less than .05 was considered
statistically significant. All analyses were performed with SAS software
(version 8.2; SAS Institute, Inc, Cary, NC).
RESULTS
The prevalence of preoperative atrial fibrillation in pa-
tients undergoing operations for isolated CABG was found
to be between 2.7% in the younger age group to 22.3%
for the 75- to 80-year-old patients (Table 1), with a 5.3%
calculated prevalence for the entire group of patients under-
going isolated CABG and equal distribution between sexes.902 The Journal of Thoracic and Cardiovascular SuPatients undergoing isolated CABG with preoperative
atrial fibrillation presented as older, with decreased EF,
and with increased rates of diabetes mellitus, hypertension,
and congestive heart failure compared with patients without
atrial fibrillation (Table 1).
Among patients undergoing isolated CABG, the presence
of preoperative atrial fibrillation is associated with greater
rates of all major complications (any reoperation, stroke,
prolonged ventilation time, renal failure, prolonged length
of stay, and mortality), as shown in Table 2. Patients with
preoperative atrial fibrillation undergoing CABG had higher
percentages of renal failure (6.0% vs 2.8%), prolonged hos-
pital stay (ie, postoperative length of stay>14 days; 11.3%
vs 5.1%), and mortality (5.2% vs 2.2%) than those with no
atrial fibrillation (Table 2). Despite adjusting for preopera-
tive patient characteristics, the odds of serious complications
and death were all significantly greater for patients with pre-
operative atrial fibrillation as opposed to those with no pre-
operative atrial fibrillation (Table 3). Adjusted odds for
prolonged length of stay and mortality for those with preop-
erative atrial fibrillation versus those with no atrial fibrilla-
tion were 1.41 (95% CI, 1.33–1.49) and 1.30 (95% CI,
1.20–1.41), respectively.
The relationship between preoperative atrial fibrillation
and EF for postoperative complications and mortality in
both the unadjusted and adjusted multivariate models is
shown in Table 4. There was a significant interaction be-
tween atrial fibrillation and EF for mortality, stroke, pro-
longed ventilation, and prolonged length of stay (>14
days) after adjusting for other preoperative characteristics.
The effect of preoperative atrial fibrillation (vs no atrial fi-
brillation) on outcome is greater among patients with an
EF of greater than 40%. The adjusted odds of mortality
for patients with atrial fibrillation are only 1.17 when com-
pared with patients without atrial fibrillation among the
group with an EF of 40% or less. However, the odds of
death for patients with atrial fibrillation are 1.47 and 1.37
compared with patients without atrial fibrillation among
those with EFs of 40% to 55% and greater than 55%,
respectively.
Similarly, adjusted ORs for postoperative length of stay
for those with preoperative atrial fibrillation versus those
with no preoperative atrial fibrillation are 1.22 (95% CI,
1.12–1.33) among patients with EFs of 40% or less, 1.56
(95% CI, 1.42–1.72) among those with EFs of 40% to
55%, and 1.60 (95% CI, 1.43–1.79) among those with
EFs of greater than 55%. There was no strong evidence of
an interaction between atrial fibrillation and age or atrial fi-
brillation and body mass index.
DISCUSSION
The prevalence of atrial fibrillation among patients under-
going isolated CABG (5.3%) is consistent with the reported
literature. Patients admitted for CABG with a history ofrgery c April 2009
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DTABLE 1. Preoperative demographic and clinical characteristics, 2002–2003
Isolated CABG
Total No preoperative AF Preoperative AF
Parameter N % N % N % P value
Age <50 y 28,610 10.6 28,253 10.6 357 2.7 .001
50–55 y 29,613 10.5 28,998 10.9 615 3.9
55–60 y 38,633 13.7 37,517 14.1 1116 7.8
60–65 y 41,856 14.9 40,171 15.1 1685 10.7
65–70 y 44,619 15.8 42,001 15.8 2618 16.6
70–75 y 44,905 15.9 41,469 15.6 3436 21.8
75–80 y 34,344 12.2 30,823 11.6 3521 22.3
>80 y 19,105 6.8 16,694 6.3 2411 15.3
Sex M 202,290 71.8 190,908 71.8 11,382 72.2 .251
F 79,279 28.1 74,906 28.2 4373 27.8
EF >55% 99,840 35.5 95,527 35.9 4313 27.4 .001
40%–55% 110,050 39.1 104,349 39.2 5701 36.2
30%–40% 42,081 15.0 39,136 14.7 2945 18.7
30% 29,716 10.6 26,916 10.1 2800 17.8
DM 100,494 35.7 94,473 35.5 6021 38.2 .001
HTN 214,279 76.07 201,559 75.8 12,720 80.7 .001
H-Chol 199,580 70.85 189,353 71.2 10,227 64.9 .001
F Hx CAD 120,821 42.89 115,063 43.3 5758 36.5 .001
Smoke 173,481 61.59 164,149 61.7 9332 59.2 .001
CLD 53,929 19.2 49,963 18.8 3966 25.7 .001
PVD 44,926 16.0 41,432 15.6 3494 22.7 .001
CVD 38,263 13.6 34,984 13.2 3279 20.8 .001
CVA 20,421 7.5 18,525 7.0 1896 12.0 .001
Prv CAB 15,098 5.4 14,022 5.3 1076 6.8 .001
Prv PTCA 56,152 19.9 53,179 20.0 2973 18.9 .001
Prv valve 729 0.3 596 0.2 133 0.8 .001
MI 24 10,442 3.7 9886 3.7 556 3.5 .001
1–7 d 54,705 19.4 51,007 19.2 3698 23.5
8–21 d 9922 3.5 8962 3.4 960 6.1
>21 d 51,739 18.4 48,687 18.3 3052 19.4
CHF 39,556 14.0 34,692 13.1 4864 30.9 .001
NHYA III 106,665 37.9 100,328 37.7 6337 40.2 .001
IV 58,110 20.6 54,027 20.3 4083 25.9
No. diseased vessels 1 12,183 4.3 11,668 4.4 515 3.3 .001
2 56,103 19.9 53163 20.0 2940 18.7
3 212,321 75.4 200,065 75.2 12,256 77.8
LM>50% 70,697 25.1 66,141 24.9 4556 28.9 .001
Status Elective 143,094 50.8 135,970 51.1 7124 45.2 .001
Urgent 126,755 45.0 118,834 44.7 7921 50.3
Emergency 10,946 3.9 10,283 3.9 663 4.2
CABG, Coronary artery bypass grafting; AF, atrial fibrillation; EF, ejection fraction; DM, diabetes mellitus; HTN, hypertension; H-Chol, hypercholesteremia; F Hx CAD, family
history of coronary artery disease; CLD, chronic lung disease; PVD, peripheral vascular disease; CVD, cerebrovascular disease; CVA, cerebrovascular accident; Prv CAB, previous
CABG; Prv PTCA, previous percutaneous transluminal cardiac arthroplasty; Prv valve, previous valve; MI, myocardial infarction; CHF, chronic heart failure; NYHA, New York
Heart Association class; LM, left main descending.atrial fibrillation represent, in general, a higher-risk group of
patients based on their preoperative clinical variables. Pa-
tients with atrial fibrillation are older and have more risk
factors for morbidity and mortality.
Previous reports, such as the Framingham Study and
a study published by the Cleveland Clinic, documented the
same trend in patient outcomes.2,4 Other studies published
in the past have also identified preoperative atrial fibrillationThe Journal of Thoracic and Cas a risk factor for early and late mortality, as well as an in-
creased risk for stroke and bleeding.3,5-9
Although there were statistically significant interactions
between atrial fibrillation and EF with respect to mortality
and several complications, it is questionable whether the in-
teraction effects are clinically significant and truly meaning-
ful. From Table 3, of adjusted ORs for atrial fibrillation
versus no atrial fibrillation stratified by EF category, it seemsardiovascular Surgery c Volume 137, Number 4 903
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tion) on outcome is greater among patients with higher
EFs (ie, EF>40%). Among patients undergoing CABG,
the effect of preoperative atrial fibrillation on outcome was
found to be significant, despite adjusting for patient risk fac-
tors. Atrial fibrillation is a common endpoint in the natural
history of patients with significant mitral valve disease and
left atrial enlargement. However, among patients with coro-
nary artery disease and no mitral valve pathology, atrial
fibrillation might represent a subset of patients with ischemic
TABLE 2. Postoperative outcomes, 2002–2003
Patients undergoing CABG
All
No atrial
fibrillation
Atrial
fibrillation
P valueOutcome (% yes) N % N % N %
Any reoperation 17,358 6.2 15,915 6.0 1443 9.2 <.001
Stroke 4134 1.5 3729 1.4 405 2.6 <.001
Prolonged
ventilation time
21,634 7.7 19,549 7.4 2085 13.2 <.001
Renal failure 7943 3.0 7086 2.8 857 6.0 <.001
Prolonged
LOS>14 d
15,257 5.4 13,472 5.1 1785 11.3 <.001
Mortality 6759 2.4 5942 2.2 817 5.2 <.001
CABG, Coronary artery bypass grafting; LOS, length of stay.904 The Journal of Thoracic and Cardiovascular Suheart disease who should be given special consideration dur-
ing assessment and counseling on risk in addition to evalu-
ation based on left ventricular EF.
It should be clear that the findings of this study do not sug-
gest that the operative results in general were better among
patients with low EFs. However, when comparing the effect
of atrial fibrillation on mortality and morbidity within the
EF subgroups, preoperative atrial fibrillation increases the
odds of a negative effect in patients with EFs of greater
than 40%. The addition of EF as a potential modifier for
TABLE 3. Unadjusted and adjusted odds ratios for complications and
mortality by preoperative atrial fibrillation (versus none) adjusted for
potential confounders, patients undergoing CABG only
Total N
Unadjusted
OR
95%
CI
Adjusted
OR
95%
CI
Any reoperation 281,567 1.58 1.49–1.67 1.18 1.12–1.26
Stroke 281,567 1.85 1.67–2.05 1.20 1.08–1.33
Prolonged
ventilation time
281,567 1.88 1.79–1.98 1.22 1.15–1.28
Renal failure 281,567 2.19 2.04–2.36 1.28 1.19–1.37
Prolonged
LOS>14 d
281,567 2.38 2.25–2.51 1.41 1.33–1.49
Mortality 281,567 2.36 2.19–2.54 1.30 1.20–1.41
CABG, Coronary artery bypass grafting; OR, odds ratio; CI, confidence interval; LOS,
length of stay.TABLE 4. Unadjusted and adjusted odds ratios for complications and mortality by preoperative atrial fibrillation adjusted for ejection fraction
status and potential confounders, patients with CABG only
Total N Unadjusted OR 95% CI AF, EF interaction* Adjusted OR 95% CI AF, EF interaction*
Any reoperation
EF 40% 71,766 1.46 1.33–1.60 .4562 1.18 1.07–1.29 .5997
EF 40%–55% 109,999 1.49 1.35–1.64 1.15 1.04–1.27
EF>55% 99,802 1.60 1.43–1.78 1.25 1.11–1.40
Stroke
EF 40% 71,766 1.40 1.19–1.64 .0021 1.02 0.86–1.20 .0335
EF 40%–55% 109,999 2.08 1.74–2.48 1.37 1.14–1.64
EF>55% 99,802 1.99 1.61–2.46 1.33 1.07–1.64
Prolonged ventilation time
EF 40% 71,766 1.52 1.42–1.63 <.0001 1.13 1.05–1.22 .0479
EF 40%–55% 109,999 1.92 1.75–2.10 1.30 1.19–1.43
EF>55% 99,802 1.88 1.69–2.09 1.27 1.15–1.41
Renal failure
EF 40% 65,413 1.73 1.55–1.93 .0007 1.15 1.03–1.29 .0528
EF 40%–55% 104,537 2.27 2.02–2.55 1.35 1.19–1.52
EF>55% 96,095 2.34 2.01–2.72 1.43 1.23–1.66
Prolonged LOS>14 d
EF 40% 71,766 1.79 1.66–1.94 <.0001 1.22 1.12–1.33 <.0001
EF 40%–55% 109,999 2.55 2.32–2.81 1.56 1.42–1.72
EF>55% 99,802 2.59 2.32–2.90 1.60 1.43–1.79
Mortality
EF 40% 71,766 1.80 1.62–1.99 <.0001 1.17 1.04–1.31 .0344
EF 40%–55% 109,999 2.56 2.24–2.92 1.47 1.28–1.69
EF>55% 99,802 2.41 2.03–2.86 1.37 1.16–1.63
CABG, Coronary artery bypass grafting;OR, odds ratio;CI, confidence interval; AF, atrial fibrillation; EF, ejection fraction; LOS, length of stay. *P value for test of interaction score
between preoperative atrial fibrillation and ejection fraction.rgery c April 2009
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tive of a causal relationship between preoperative atrial fibril-
lation and subsequent morbidity. Among patients defined by
EFs of greater than 55%, atrial fibrillation is significantly as-
sociated with morbidity after adjustment for preoperative risk
factors compared with the association seen in patients without
atrial fibrillation. In patients predisposed to subsequent post-
operative morbidity (EF<55%), atrial fibrillation continues
to have a significant interactive effect with EF, despite adjust-
ments for traditional risk factors for postoperative morbidity.
The importance of this large-scale study was to establish the
clinical association between preoperative atrial fibrillation and
increased morbidity and mortality after CABG. However, is
there any clinical relevance for these findings? Should preoper-
ativeatrial fibrillation be identified asa risk factor to be included
in risk-prediction models, such as the STS score? Based on this
study, no absolute answer can be given, but the results would
suggest that special attention should be given to candidates
for CABG when assessing the operative risk and the expected
outcome. The results of the present study should encourage
developers of preoperative risk algorithms to consider atrial
fibrillation as a risk factor in cardiac surgery preoperative risk
algorithms, as was done by the STS, which included preopera-
tive arrhythmia in the risk model for STS version 2.61.
Surgical ablation of atrial fibrillation has been advocated
as a useful adjunctive procedure in the care of patients under-
going cardiac surgery and having a documented significant
history of atrial fibrillation. The results of the combined
and isolated procedure have been very good, with relatively
low mortality and morbidity, and have resulted in a signifi-
cant reduction in the risk for long-term thromboembolic
events and strokes.10-13 Recent developments in ablation
technologies enhance the ability of surgeons to create the
different lesions in a very precise and efficient way.14-16
Nevertheless, surgical ablation of atrial fibrillation is far
from being applied in all cases in which there is an indication
for the procedure. Theoretically, ablation of atrial fibrillation
in patients undergoing CABG alone should improve the out-
come of the patients and reduce the risk for late strokes. Un-
fortunately, there are no surgical data stratified by risk
factors that can support this assumption. In the electrophys-
iology literature there are scattered studies to support abla-
tion of atrial fibrillation in patients with low EF, such as
the study by Chen and colleagues,17 which documented sig-
nificant improvement in left ventricular function and func-
tional class in patients with low EFs after successful
percutaneous ablation. The positive effect of surgical abla-
tion on early outcome is questionable. A meta-analysis of
the literature for patients with valve disease and atrial fibril-
lation revealed improvement in the perioperative results for
those patients with a concomitant ablation procedure.18 A re-
cent publication from the Mayo Clinic19 suggested that pre-
operative atrial fibrillation that was not addressed at the time
of CABG is associated with increased risk for late mortalityThe Journal of Thoracic and Cand morbidity and less favorable long-term survival and
therefore recommended surgical correction of atrial fibrilla-
tion at the time of CABG.
The question of whether preoperative atrial fibrillation is
a marker of sicker patients or causally related to less favor-
able outcomes after CABG as a standalone procedure or
combined with mitral valve surgery is very important. How-
ever, such a causal relationship can only be determined
through prospective clinical trials. Lastly, the type of atrial
fibrillation is not a variable that is currently being collected
by the STS, and therefore the variability in the definition of
the arrhythmia by the data collectors in the different centers
is uncontrolled. Thus the potential effect of the type of atrial
fibrillation could not be determined and should be consid-
ered a limitation of the study.
In this study we were able to show, in a large cohort of pa-
tients, that preoperative atrial fibrillation is associated with
an increased risk for perioperative mortality and morbidity
in patients undergoing CABG. Given all the familiar limita-
tions associated with retrospective studies, we can carefully
claim that in the low-EF group atrial fibrillation might signal
a high-risk patient, and attention should be given when ap-
proaching such patients before surgical intervention for dis-
cussion of the risks of the surgical procedure. As for patients
with good left ventricular function presenting for CABG, the
presence of preoperative atrial fibrillation alone might be re-
lated to increased morbidity and mortality in which ablation
of atrial fibrillation might theoretically improve the out-
come. However, such a statement can be supported only af-
ter a prospective randomized study. Cardiac surgeons should
be familiar with the association between atrial fibrillation
and patients’ outcome after CABG and also be able to apply
modern techniques proved to be effective in treating atrial fi-
brillation. We also encourage ongoing outcomes studies and
clinical research to evaluate developing techniques and their
applications and indications to help build the necessary ev-
idence to guide surgeons in their clinical decision making.
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